These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells. Havell EA Arch Virol; 1980; 65(3-4):229-36. PubMed ID: 6158304 [TBL] [Abstract][Full Text] [Related]
48. High-yield interferon induction by 10-carboxymethyl-9-acridanone in mice and hamsters. Taylor JL; Schoenherr CK; Grossberg SE Antimicrob Agents Chemother; 1980 Jul; 18(1):20-6. PubMed ID: 6158292 [TBL] [Abstract][Full Text] [Related]
49. Effective antiviral prophylaxis and therapy by systemic application of human interferon in immunosuppressed monkeys. Neumann-Haefelin D; Shrestha B; Manthey KF J Infect Dis; 1976 Jun; 133 Suppl():A211-6. PubMed ID: 180202 [TBL] [Abstract][Full Text] [Related]
51. Distribution of interferon in body fluids and tissues. Bocci V Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467 [No Abstract] [Full Text] [Related]
52. IFN induction and associated changes in splenic leukocyte distribution. Ishikawa R; Biron CA J Immunol; 1993 May; 150(9):3713-27. PubMed ID: 7682583 [TBL] [Abstract][Full Text] [Related]
53. [Method of increasing the activity of a preparation of human cadaver leukocyte interferon]. Parfenov VV; Zubanova NA; Mekhedov LN; Pokidysheva LN; Kuznetsov VP Vopr Virusol; 1980; (3):294-7. PubMed ID: 6159731 [TBL] [Abstract][Full Text] [Related]
54. [Study of the catabolism of interferon, using the isolated and perfused liver]. Pessina GP; Pacini A; Bargigli V; Russi-Sorce M; Bocci V Boll Soc Ital Biol Sper; 1976 May; 52(10):651-7. PubMed ID: 949376 [No Abstract] [Full Text] [Related]
55. Target cells for interferon induction by BL-20803. Siminoff P J Infect Dis; 1976 Jun; 133 Suppl():A37-42. PubMed ID: 932505 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures. Weck PK; Apperson S; May L; Stebbing N J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550 [TBL] [Abstract][Full Text] [Related]
57. Pleural effusion disease in rabbits. Interferon in body fluids and tissues after experimental infection. Fennestad KL; Haahr S; Bruun L Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):311-5. PubMed ID: 525355 [TBL] [Abstract][Full Text] [Related]
58. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons. Kandefer-Szerszeń M Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874 [TBL] [Abstract][Full Text] [Related]
59. Rat leukocyte interferons: production of an acid-labile interferon after induction with Newcastle disease virus. Wiedbrauk DL; Burleson GR J Leukoc Biol; 1987 Jul; 42(1):21-9. PubMed ID: 2439625 [TBL] [Abstract][Full Text] [Related]
60. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]